Aspen Aerogels Past Earnings Performance
Past criteria checks 0/6
Aspen Aerogels's earnings have been declining at an average annual rate of -39.2%, while the Chemicals industry saw earnings growing at 6.3% annually. Revenues have been growing at an average rate of 32.5% per year.
Key information
-39.17%
Earnings growth rate
-12.59%
EPS growth rate
| Chemicals Industry Growth | 12.93% |
| Revenue growth rate | 32.52% |
| Return on equity | -101.02% |
| Net Margin | -78.53% |
| Next Earnings Update | 06 Nov 2025 |
Recent past performance updates
Recent updates
Optimistic Investors Push Aspen Aerogels, Inc. (NYSE:ASPN) Shares Up 27% But Growth Is Lacking
Oct 11
Aspen Aerogels: Still Many Questions After A Big Setback
Aug 10Aspen Aerogels, Inc. (NYSE:ASPN) Analysts Are Pretty Bullish On The Stock After Recent Results
Aug 09Aspen Aerogels, Inc.'s (NYSE:ASPN) Shares Climb 28% But Its Business Is Yet to Catch Up
Aug 06Is Aspen Aerogels (NYSE:ASPN) A Risky Investment?
Jul 09Aspen Aerogels, Inc.'s (NYSE:ASPN) 29% Share Price Surge Not Quite Adding Up
Jun 11Not Many Are Piling Into Aspen Aerogels, Inc. (NYSE:ASPN) Stock Yet As It Plummets 30%
Apr 17Aspen Aerogels (NYSE:ASPN) Has A Pretty Healthy Balance Sheet
Apr 01Aspen Aerogels: Tariffs, Tesla And The Silver Lining
Mar 31Positive Sentiment Still Eludes Aspen Aerogels, Inc. (NYSE:ASPN) Following 34% Share Price Slump
Feb 28Aspen Aerogels: Insulation Play Leaves Investors In The Cold
Feb 14Aspen Aerogels (NYSE:ASPN) Is Looking To Continue Growing Its Returns On Capital
Feb 14Aspen Aerogels: There Are Reasons To Be Careful But It's So Cheap
Dec 23Aspen Aerogels: Thermal Barriers Could Sustain Further Growth Despite A Chilly Market
Dec 02Aspen Aerogels: Despite Recent Pressure, This Is Intriguing
Nov 17With A 32% Price Drop For Aspen Aerogels, Inc. (NYSE:ASPN) You'll Still Get What You Pay For
Nov 07Aspen Aerogels: Interesting Times
Oct 28Aspen Aerogels (NYSE:ASPN) Is Looking To Continue Growing Its Returns On Capital
Oct 17Aspen Aerogels: Current Valuation Is Not A Good Risk/Reward
Sep 26Aspen Aerogels: Management Guidance Remains Very Conservative
Sep 18
Decisive Expansion And EV Innovations Propel Aerogel Giant Towards Financial Triumph
Expansion of production capacity and strategic financial management shows promise for significant revenue growth and improved net income through cost efficiency.Why Investors Shouldn't Be Surprised By Aspen Aerogels, Inc.'s (NYSE:ASPN) 32% Share Price Surge
Aug 24Investors Shouldn't Be Too Comfortable With Aspen Aerogels' (NYSE:ASPN) Earnings
Aug 15Aspen Aerogels: Impressive, But Some Questions As Well
Aug 12We Think Aspen Aerogels (NYSE:ASPN) Has A Fair Chunk Of Debt
Jul 21Aspen Aerogels: Moving Towards Profitability
Jul 12Aspen Aerogels, Inc.'s (NYSE:ASPN) Popularity With Investors Is Clear
Jun 24Health Check: How Prudently Does Aspen Aerogels (NYSE:ASPN) Use Debt?
Apr 05Aspen Aerogels: Impressive And Intriguing
Mar 25Aspen Aerogels, Inc. (NYSE:ASPN) Looks Just Right With A 53% Price Jump
Mar 08Analysts Have Made A Financial Statement On Aspen Aerogels, Inc.'s (NYSE:ASPN) Full-Year Report
Feb 15Revenue & Expenses Breakdown
How Aspen Aerogels makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 25 | 397 | -312 | 96 | 17 |
| 31 Mar 25 | 437 | -286 | 103 | 18 |
| 31 Dec 24 | 453 | 13 | 107 | 18 |
| 30 Sep 24 | 414 | 1 | 104 | 18 |
| 30 Jun 24 | 357 | 1 | 101 | 17 |
| 31 Mar 24 | 288 | -31 | 95 | 17 |
| 31 Dec 23 | 239 | -46 | 90 | 16 |
| 30 Sep 23 | 214 | -55 | 85 | 16 |
| 30 Jun 23 | 190 | -71 | 78 | 17 |
| 31 Mar 23 | 188 | -80 | 74 | 17 |
| 31 Dec 22 | 180 | -83 | 67 | 17 |
| 30 Sep 22 | 152 | -89 | 59 | 16 |
| 30 Jun 22 | 146 | -68 | 53 | 14 |
| 31 Mar 22 | 132 | -50 | 45 | 13 |
| 31 Dec 21 | 122 | -37 | 39 | 11 |
| 30 Sep 21 | 113 | -27 | 35 | 10 |
| 30 Jun 21 | 107 | -26 | 30 | 9 |
| 31 Mar 21 | 100 | -25 | 28 | 9 |
| 31 Dec 20 | 100 | -22 | 27 | 9 |
| 30 Sep 20 | 124 | -17 | 29 | 9 |
| 30 Jun 20 | 135 | -12 | 31 | 9 |
| 31 Mar 20 | 140 | -12 | 31 | 9 |
| 31 Dec 19 | 139 | -15 | 32 | 8 |
| 30 Sep 19 | 129 | -28 | 33 | 8 |
| 30 Jun 19 | 117 | -32 | 32 | 7 |
| 31 Mar 19 | 109 | -34 | 33 | 7 |
| 31 Dec 18 | 104 | -34 | 33 | 6 |
| 30 Sep 18 | 105 | -22 | 30 | 6 |
| 30 Jun 18 | 108 | -19 | 30 | 6 |
| 31 Mar 18 | 112 | -17 | 30 | 6 |
| 31 Dec 17 | 112 | -19 | 32 | 6 |
| 30 Sep 17 | 103 | -23 | 32 | 6 |
| 30 Jun 17 | 105 | -23 | 33 | 6 |
| 31 Mar 17 | 108 | -19 | 32 | 6 |
| 31 Dec 16 | 118 | -12 | 29 | 5 |
| 30 Sep 16 | 127 | -5 | 28 | 5 |
| 30 Jun 16 | 129 | -4 | 27 | 5 |
| 31 Mar 16 | 132 | -5 | 27 | 5 |
| 31 Dec 15 | 123 | -6 | 26 | 5 |
| 30 Sep 15 | 113 | -11 | 25 | 6 |
| 30 Jun 15 | 107 | -11 | 25 | 6 |
| 31 Mar 15 | 104 | -50 | 28 | 6 |
| 31 Dec 14 | 102 | -66 | 27 | 6 |
Quality Earnings: ASPN is currently unprofitable.
Growing Profit Margin: ASPN is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: ASPN is unprofitable, and losses have increased over the past 5 years at a rate of 39.2% per year.
Accelerating Growth: Unable to compare ASPN's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: ASPN is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (3.7%).
Return on Equity
High ROE: ASPN has a negative Return on Equity (-101.02%), as it is currently unprofitable.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/10/17 11:10 |
| End of Day Share Price | 2025/10/17 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Aspen Aerogels, Inc. is covered by 18 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Benjamin Kallo | Baird |
| J. David Anderson | Barclays |
| J. David Anderson | Barclays |